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Background: ABC exporters are suggested to 
hydrolyze ATP sequentially implying the existence 
of asymmetries. 
Results: An in vitro selected binder (DARPin) was 
identified which binds to homodimeric MsbA at a 
stoichiometric ratio of 1:1. 
Conclusion: The DARPin recognizes asymmetries 
in MsbA.  
Significance: Selected binding proteins are useful 
tools to recognize membrane transporters in novel 
conformational states. 
 
SUMMARY 
ABC transporters harness the energy from 
ATP binding and hydrolysis to translocate 
substrates across the membrane. Binding of two 
ATP molecules at the nucleotide binding domains 
(NBDs) leads to the formation of an outward-
facing state.  The conformational changes 
required to reset the transporter to the inward-
facing state are initiated by sequential hydrolysis 
of the bound nucleotides. In a homodimeric ABC 
exporter such as MsbA responsible for lipid A 
transport in E. coli, sequential ATP hydrolysis 
implies the existence of an asymmetric 
conformation. Here we report the in vitro 
selection of a designed ankyrin repeat protein 
(DARPin) specifically binding to detergent-
solubilized MsbA. Only one DARPin binds to the 
homodimeric transporter in the absence as well 
as in the presence of nucleotides, suggesting that 
it recognizes asymmetries in MsbA. DARPin 
binding increases the rate of ATP hydrolysis by a 
factor of two independent of the substrate-
induced ATPase stimulation. Electron 
paramagnetic resonance (EPR) measurements 
are found to be in good agreement with the 
available crystal structures and reveal that 
DARPin binding does not affect the large 
nucleotide-driven conformational changes of 
MsbA. The binding epitope was mapped by 
cross-linking and EPR to the membrane-
spanning part of the transmembrane domain 
(TMD). Using cross-linked DARPin-MsbA 
complexes, 8-azido-ATP was found to 
preferentially photolabel one chain of the 
homodimer, suggesting that the asymmetries 
captured by DARPin binding at the TMDs are 
propagated to the NBDs. This work demonstrates 
that in vitro selected binders are useful tools to 
study the mechanism of membrane proteins. 
 
ATP-binding Cassette (ABC) transporters are 
primary active transporters, which act as exporters, 
importers, receptors and channels. These 
transmembrane proteins mediate a plethora of 
physiological phenomena, including transport of 
metabolic products, nutrients, proteins, peptides, 
lipids, polysaccharides, ions and drugs (1). In 
humans, malfunction of ABC transporters leads to 
several genetic disorders including cystic fibrosis, 
neurological diseases, retinal degeneration, 
cholesterol and bile transport defects, anemia, and 
insufficient drug response.  
MsbA is a homodimeric ABC exporter involved in 
the transport of lipid A and lipopolysaccharides to 
 http://www.jbc.org/cgi/doi/10.1074/jbc.M112.359794The latest version is at 
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the outer leaflet of the inner membrane in bacteria 
(2) and  the msbA gene is essential in E. coli (3). 
MsbA is homologous to the multidrug transporter 
LmrA of gram-positive Lactococcus lactis (4) and 
mammalian multidrug resistance transporters such as 
P-glycoprotein (5) and shows overlapping substrate 
specificity with them (6,7). At a molecular level, 
ABC transporters consist of four domains, two 
transmembrane domains (TMDs) and two 
nucleotide-binding domains (NBDs). In ABC 
exporters, the TMDs are composed of at least six 
transmembrane helices, which form the substrate 
transport pathway and provide specificity. The 
NBDs are also known as ATP-binding cassettes and 
drive the transport cycle by binding and hydrolyzing 
ATP. The motional energy of the NBDs are coupled 
to conformational changes in the TMDs which 
alternate between an inward- and an outward-facing 
state and thereby form a pathway to mediate 
unidirectional transport across the membrane (8). 
Current molecular understanding of ABC exporters 
is based on crystal structures of Sav1866 (8) solved 
at 3 Å in its outward-facing state,  P-glycoprotein 
solved at 3.8 Å in its inward-facing state  (5) and the 
structures of three homologues of MsbA solved in 
three different conformations at resolutions ranging 
from 3.7 Å to 5.5 Å (9). Based on these crystal 
structures, large conformational changes are 
expected to occur in ABC exporters upon nucleotide 
binding and hydrolysis, which could be confirmed 
by cross-linking experiments and EPR 
measurements (10-14). 
The mechanistic details of how the binding and 
hydrolysis of ATP at the NBDs is coupled to the 
transport process at the TMDs are still a matter of 
controversy. In many heterodimeric ABC 
transporters, one of the two ATPase sites deviates 
from the consensus sequence and is therefore called 
the degenerate site (15). Such heterodimeric ABC 
exporters mainly hydrolyze ATP at the consensus 
site and thus operate in an asymmetric fashion. In 
homodimeric ABC exporters such as BmrA as well 
as in P-glycoprotein which is a fused heterodimer 
but exhibits two consensus ATPase sites, 
biochemical experiments demonstrated that only one 
ATP molecule is trapped by vanadate in the post-
hydrolytic state per ABC transporter dimer (16,17). 
It was concluded that ABC exporters hydrolyze the 
two ATP molecules sequentially instead of 
simultaneously, possibly involving a mechanism of 
alternating catalytic sites (18). This mechanism 
implies that the NBD homodimer must switch to an 
asymmetric conformation before ATP is hydrolyzed 
at one of the two catalytic sites. In support of this 
notion, asymmetric homodimers have been observed 
in crystal structures of the ATP-bound NBDs of the 
ABC transporter HlyB (19). On the other hand, 
current crystal structures of outward-facing MsbA 
and Sav1866 feature two bound AMP-PNP at the 
NBDs (thus representing a pre-hydrolytic state) and 
display only minor structural differences between 
the two chains, that are related by two-fold non-
crystallographic symmetry (9,20). Molecular 
dynamics simulation using the symmetric Sav1866 
and MsbA structures as starting points revealed that 
the NBDs readily switch to an asymmetric state in 
which only one molecule of ATP enters the 
hydrolysis reaction at a time (21,22).  Further work 
addressing the question of asymmetry in ABC 
exporters is clearly needed to resolve the apparent 
discrepancies between asymmetries found based on 
biochemical experiments and the symmetric crystal 
structures of the homodimers Sav1866 and MsbA. 
Designed Ankyrin Repeat Proteins (DARPins) 
represent a well-established randomized scaffold 
used as an alternative to antibody fragments (Fabs 
and scFvs) and have been selected against a variety 
of target proteins (23-25). A growing number of 
DARPin co-crystal structures demonstrate the 
successful application of such designed binding 
proteins as crystallization aids (24). Besides possible 
improvements of crystal diffraction, DARPins have 
the potential to trap the targeted protein in alternate 
conformations. DARPins selected against the 
multidrug transporter AcrB for example trap this 
protein in an asymmetric state with two DARPins 
bound to the homotrimer (25,26). In the absence of 
DARPins, AcrB was initially crystallized in its 
symmetric and later in its asymmetric state (27,28). 
Here, we describe the selection of DARPins against 
detergent-purified MsbA using ribosome display. 
We identified a DARPin which binds to the 
homodimeric transporter in a 1:1 stoichiometric 
ratio. The DARPin binding epitope was mapped to 
the TMDs and was found to be located away from 
the 2-fold symmetry axis of MsbA, suggesting that 
the DARPin recognizes asymmetries in MsbA. 
DEER measurements revealed that addition of the 
DARPin to MsbA does not influence the large ATP-
induced conformational changes during transporter 
cycling. Nevertheless, DARPin binding enhances the 
basal ATPase activity of the transporter without 
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impairing the substrate-induced stimulation 
suggesting that the catalytic cycle is accelerated 
when asymmetric MsbA conformations are 
populated. 
 
EXPERIMENTAL PROCEDURES 
 
Purification, biotinylation and spin labeling of 
MsbA and DARPin – A detailed description of the 
cloning, expression and purification of MsbA is 
given in the Supplementary Experimental 
Procedures. MsbA was expressed in E. coli C43 
(DE3) cells from a pBAD vector and purified using 
β-UDM as detergent. DARPin expression and 
purification has been described previously (29). 
Enzymatic biotinylation was facilitated by fusing an 
Avi-tag sequence to the C-terminus of MsbA. Single 
cysteine mutants at positions A25C, R103C, N191C, 
S206C and S246C of MsbA were introduced by site 
directed mutagenesis taking cys-less msbA 
(C88S/C315S) as template. Likewise, single cysteine 
mutants were also introduced into the N- and C- 
terminal caps of DARPin_55 (which is cys-less by 
design) at the positions S12C, K16C, E29C, D151C 
and D160C. For methanethiosulfonate cross-linking 
and spin labeling, single cysteine mutants of MsbA 
and DARPin were purified by supplementing 5 mM 
dithiothreitol (DTT) which was removed (PD-10 
column, GE Healthcare) prior to  labeling with 10 
times molar excess of MTSSL ( (1-Oxyl-2,2,5,5-
tetramethyl-∆3-pyrroline-3-methyl) 
methanethiosulfonate; Toronto Research 
Chemicals). Excess spin label was removed by size 
exclusion chromatography. For the EPR 
measurements, DARPin-MsbA complexes were 
made by spin labeling the freshly purified proteins 
individually, followed by gel-filtration of the protein 
complex. 
 
 
Selection and Screening of DARPin specific to 
MsbA – The N3C DARPin library (23) was used for 
binder selection by ribosome display as described 
(30,31). Four rounds of selections were carried out 
following the solution panning strategy (29). 0.05% 
of β-UDM were used to maintain MsbA in active 
form.  Single clones of the enriched pool of 
DARPins from the 4
th
 selection round were 
expressed from the vector pQE30myc5 (29) in E. coli 
XL-1 Blue yielding DARPins carrying an N-
terminal RGS-His6 tag (M-R-G-S-H-H-H-H-H-H) 
and a C-terminal Myc5-tag (5 times amino acid 
sequence M-E-Q-K-L-I-S-E-E-D-L-N-E). Single 
DARPin clones were analyzed for binding to 
bMsbAAviC by crude cell extract ELISAs as 
described previously (29). 
 
SEC of isolated DARPins and the MsbA-DARPin 
complexes – ELISA-positive MsbA-specific 
DARPins were subcloned into pQE30 (Qiagen) 
devoid of the C-terminal Myc5–tag for further 
biochemical analysis. A molar excess (2 to 3 times) 
of freshly gel-filtrated monomeric DARPins were 
mixed with MsbA and incubated in 20 mM Tris/HCl 
(pH 7.5), 150 mM NaCl, and 0.05 % β-UDM for at 
least 30 min at 4°C for complex formation. The 
protein complex was separated on a Superdex 200 
10/300 GL column (GE Healthcare) (Fig. S4). The 
fractions corresponding to the MsbA-DARPin 
complex were analyzed by on-chip protein analysis 
according to the manufacturer’s protocol (Protein 80 
Kit, Agilent Technologies) (Fig. S8). 
 
Cysteine cross-linking of MsbA and DARPin_55 
mutants – For cross-linking studies, two thiol-
specific homobifunctional cross-linkers namely 
M5M (1,5-Pentanediyl Bismethanethiosulfonate, 
Toronto Research Chemicals) and M11M (3,6,9-
Trioxaundecane-1,11-diyl-bismethanethiosulfonate, 
Toronto Research Chemicals) with spacer arms of 
9.1 Å and 16.9 Å were used (32). The MsbA and 
DARPin_55 mutant proteins were mixed at ratios of 
1:3 and incubated with 0.5 mM of cross-linker for 
15 minutes at 4 °C (if not stated otherwise). The 
reactions were stopped by addition of SDS sample 
buffer and separated by non-reducing SDS-PAGE. 
The ability of DARPin_55_29C to cross-link to 
MsbA_191C was also tested using inside-out 
membrane vesicles (ISOVs) containing 
overexpressed MsbA_191C (with detergent purified 
MsbA_191C, this cross-link is readily formed). To 
this end, MsbA_191C containing ISOVs (6 mg in 
3ml) were mixed with DARPin_55_29C (35 mg in 7 
ml) and M11M (1 mM) was added. After incubation 
for 30 min, N-ethylmaleimide (NEM, 10 mM) was 
added to react with the remaining free cysteines for 
another 30 min. Subsequently, MsbA was purified 
according to the standard protocol and subjected to 
non-reducing SDS-PAGE (Fig. S8).  
 
ATPase assay – The ATPase activity of purified 
protein was measured from the release of Pi from 
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ATP in a colorimetric malachite green assay as 
described (33). Briefly, purified protein (200 nM) in 
50 mM K-HEPES buffer pH 7.4 containing 0.05 % 
β-UMD, 2.5 mM MgCl2 and 2 mM ATP was 
incubated at 30 °C in a total reaction volume of 50 
µl for 10-15 minutes. MsbA was inactivated by 
heating at 80°C for 2 min and free Pi was measured 
using malachite green solution. The OD600 of the 
samples was measured in a Microplate reader 
Infinite M100 (TECAN) and compared with the 
OD600 of standards containing 0.5–4 nmol Pi. 
Readings were corrected for Pi contamination 
originating from the ATP and buffer. DARPin_55-
stimulated ATPase activity of MsbA was performed 
by adding DARPin_55 at concentrations as indicated 
to MsbA (200 nM) 15 min prior to the assay start. 
All cysteine mutants used in this study showed 
ATPase activity comparable to the wild-type. Spin 
labeling did not affect the activity of MsbA 
(Supplementary Table S1). 
 
Reconstitution of MsbA into liposomes – 
Detergent-purified MsbA was reconstituted into 
lipid membrane vesicles made of polar E. coli lipids 
and egg phosphatidylcholine mixed at a ratio of 3:1 
(34). For EPR and DARPin binding experiments, the 
reconstitution buffer was 20 mM Tris/HCl pH 7.4, 
150 mM NaCl, for ATPase activity measurements it 
was 50 mM K-HEPES pH 7.0. MgCl2 was added 
only where indicated shortly before performing 
ATPase activity or EPR experiments in order to 
avoid aggregation of the liposomes. The amount of 
reconstituted MsbA was determined by the Biorad 
DC Protein Assay according to manufacturer’s 
protocol and compared BSA protein concentration 
standards. Binding of DARPin_55 to the 
reconstituted MsbA was tested by incubating the 
DARPin_55 with reconstituted MsbA (3:1 ratios) or 
empty liposomes for 15 minutes at 4°C.  Unbound 
DARPin_55 was removed by three buffer washes 
after centrifugation at 20000 g for 20 minute at 4 °C. 
The pelleted liposomes were dissolved in SDS 
buffer and were separated by SDS-PAGE (15% 
acrylamide gel) followed by SYPRO ruby staining 
(Fig. S6B).  
 
Distance measurements by pulse EPR 
experiments – Dipolar time evolution data were 
acquired using the four-pulse DEER (Double 
Electron Electron Resonance) experiment (35). 
DEER traces were measured in a home-made high 
power Q band spectrometer equipped with a home-
made oversized resonator (36). In Q band all pulse 
lengths were set to 12 ns and deuterium modulation 
artefacts were averaged (8 times d1 time increment 
of 16 ns). The pump frequency was placed at the 
maximum intensity of the nitroxide spectrum, and 
the observer frequency 80 MHz lower. All samples 
were prepared independently from different batches 
and the DEER traces were found to be reproducible. 
Samples contained 10% (v/v) d8-glycerol and were 
shock-frozen in liquid nitrogen before measurement. 
Data analysis was performed with the software 
DeerAnalysis 2010 (37). The simulation of the 
possible spin label rotamers attached at selected 
positions in MsbA was performed using the Matlab 
program package MMM (freely available at 
http://www.epr.ethz.ch/software/index) based on a 
rotamer library approach (38). 
 
8-N3-[α-
32
P]ATP photolabeling – MsbA191C 
(1.5 µM) and DARPin_55_29C (6 µM) were cross-
linked with M11M (1.5 mM) in 20 mM Tris pH 7.5, 
150 mM NaCl, 0.05 % β-UDM containing 3 mM 
MgCl2. 8-N3-[α-
32
P]ATP (1 µM, 0.6 Ci/mmol) was 
added to 10 µl protein sample (quadruplicates) and 
the reaction mixtures were incubated at 25 °C for 5 
minutes followed by UV irradiation (100 millijoules, 
UV cross-linker, Hoefer) on ice. Labeled cross-
linked MsbA-DARPin complex was analyzed by 
SDS-PAGE and photolabeling was quantified using 
a phosphor imager (Molecular Dynamics, Storm 
840). To analyze the amount of cross-linking, four 
aliquots were supplemented with cold 8-N3-ATP 
followed by UV radiation, SDS-PAGE and staining 
with SYPRO Ruby (Invitrogen). The fluorescent 
signal was read with the LAS-3000 imaging system 
and the bands were quantified using the Aida 
software (Raytest). 
 
RESULTS 
 
In vitro selection and identification of DARPins 
specific for MsbA – DARPin  selection against 
biotinylated avi-tagged MsbA (bMsbAAviC) was 
performed using ribosome display with a DARPin 
library containing three randomized modules 
(23,31,39) (Fig. S1). From 2000 DARPin clones 
analyzed for binding to bMsbAAviC by an initial 
ELISA (Fig. S2), 42 DARPins were further analyzed 
using a specificity ELISA in which besides 
bMsbAAviC the ABC transporter LmrCD and the 
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secondary-active multidrug transporter AcrB (both 
prepared as biotinylated Avi-tagged proteins) were 
used (Fig. S3). This assay revealed 37 MsbA-
specific DARPins that were further analyzed by 
size-exclusion chromatography. 27 of these 
DARPins displayed various degrees of 
oligomerization (soluble aggregates) and 6 of them 
showed monomer/dimer equilibrium and were 
therefore excluded. The remaining 4 MsbA-specific 
DARPins were monomeric but only one DARPin 
(named DARPin_55) formed a stable complex with 
MsbA that could be isolated by size exclusion 
chromatography (Fig. S4). The affinity of 
DARPin_55 for MsbA was estimated by 
competition ELISA (23), in which the binding of 
bMsbAAviC to immobilized DARPin_55myc5 was 
competed by pre-incubation with increasing amounts 
of free DARPin_55. The dissociation constant KD 
derived from these experiments was 80 nM (Fig. 
S5). Hence, from 2000 potential DARPin binders 
analyzed, we could identify one specific high-
affinity binder (Fig. 1A). 
 
The ATPase activity of MsbA is stimulated upon 
complex formation with DARPin_55 –The effect of 
DARPin binding to MsbA was studied with respect 
to the ATPase activity of the transporter. The basal 
ATPase activity of detergent-purified MsbA (200 
nM) was stimulated up to 2.1 fold upon complex 
formation with DARPin_55 (serial dilution from 50 
nM to 1.6 µM) in a dose-dependent manner reaching 
its maximum at a concentration of 400 nM 
DARPin_55 (Fig. 1C). Addition of the control 
DARPin E3_5 (39,40) did not alter the ATPase 
activity of MsbA and DARPin_55 alone did not 
hydrolyze ATP. By determining the Michaelis–
Menten kinetics of ATP hydrolysis it was found that 
DARPin_55 binding increases the maximal velocity 
Vmax (increase from 162±9 to 255±8 nmole 
Pi/min/mg MsbA) while the apparent Km of the 
ATPase activity remains unchanged (102±22 and 
117±14 µM ATP for MsbA and the 
MsbA/DARPin_55 complex, respectively) (Fig. 
1D). Lipid A and daunomycin are known substrates 
of MsbA and were found to stimulate the ATPase 
activity of the detergent-purified transporter about 
two fold in the absence (41) and 3-4 fold in complex 
with DARPin_55. This implies that drug-induced 
and DARPin_55-mediated stimulations of the basal 
ATPase activity of MsbA are additive (Fig. 1E and 
F). Therefore, DARPin binding does not appear to 
interfere with MsbA’s capability to bind its cargo 
substrates. MsbA and the MsbA_E506Q (42) mutant 
(whose ATPase activity is abolished) were 
reconstituted in proteoliposomes (34). The addition 
of lipid A and daunomycin stimulate the ATPase 
activity of reconstituted MsbA about two-fold as 
described previously (Fig. S6) (41). In contrast to 
detergent-purified MsbA the basal ATPase activity 
of reconstituted MsbA was not stimulated by the 
addition of DARPin_55, because DARPin_55 does 
not bind to membrane-embedded MsbA as discussed 
below (Fig. S7).   
 
Binding of DARPin does not impair MsbA’s 
ability to undergo conformational changes –To 
study the possible structural effects induced by 
DARPin binding to the transporter, single cysteine 
mutants of MsbA were labeled with MTSSL 
(methanothiosulfonate spin label) and interspin 
distances between the two labeled sites were 
measured by Double Electron Electron Resonance 
(DEER) in the apo- and AMP-PNP-bound states. 
The DEER analysis on two representative spin-
labeled sites (position 191 in the TMDs and position 
539 in the NBDs) is presented in Fig. 2. The 191-
191 distance in the apo-state centered at 5.8 nm was 
found to be in line with the apo crystal structure 
(43), showing a Cα-Cα distance of 4.7 nm. The 
distance decreased to 4.1 nm upon addition of AMP-
PNP and MgCl2 (Fig. 2A), which fully agrees with 
the interspin distance simulated with the program 
MMM (38) based on the AMP-PNP structure of 
MsbA (43). Upon complex formation with 
DARPin_55, MsbA showed the same distance 
distributions, indicating that the detergent-
solubilized MsbA retained the ability to accomplish 
the conformational changes induced by nucleotide 
binding (Fig. 2A).  
The AMP-PNP-state exhibited a sharp 1.8 nm 
distance between the two 539 labels located in the 
NBDs, both in the absence and presence of 
DARPin_55 (Fig. 2B). The obtained distance is 
again in perfect agreement with the crystallographic 
data, strongly indicating that DARPin binding does 
not lead to major structural changes in MsbA. The 
apo-state of the 539 mutant of MsbA showed a peak 
at about 6 nm in line with the inverted V-shaped apo 
crystal structure (43), which is characterized by a 
Cα-Cα distance of 6.4 nm. A second broad peak 
between 2 and 4 nm was present which might 
represent intermediate conformations adopted during 
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NBD closure or disengagement. However, these 
short distances were only observed in this particular 
mutant and they were strongly suppressed after 
reconstitution into liposomes (Fig. S6). Interestingly, 
adding DARPin_55 to the apo-state of the 539 
mutant of MsbA diminished the short distances but 
did not affect the 6 nm peak suggesting a 
stabilization of the open-apo structure by 
DARPin_55 in analogy to the reconstitution into 
liposomes (Fig. 2B, Fig. S6). Taking into 
consideration all tested mutants, the inverted V-
shaped crystal structure and the outward-facing 
AMP-PNP bound structure (9) appear to describe the 
conformational changes of detergent-solubilized 
MsbA appropriately.  
 
DARPin_55 binds to the transmembrane domain 
of detergent-purified MsbA – To  delineate the 
binding epitope of DARPin_55 on full-length MsbA 
we used purified sub-domains of MsbA, namely the 
TMD and the NBD. For this purpose, the domains 
were purified as Avi-tagged biotinylated proteins 
(bTMDAviC and bNBDAviC) and binding to 
DARPin_55 was assessed by the same ELISA setup 
as used to identify MsbA-specific DARPins 
described above (Fig. 1B, Fig. S2). This ELISA 
experiment revealed that DARPin_55 binds to the 
transmembrane domain (bTMDAviC) but not to the 
nucleotide binding domain (bNBDAviC) of MsbA. 
Binding of DARPin_55 to bTMDAviC resulted in a 
comparatively smaller ELISA signal than binding to 
full length bMsbAAviC. This could be due to partially 
unstructured regions on the TMDs in the absence of 
the NBDs. Binding of DARPin_55 was further 
tested using membrane vesicles containing 
overexpressed MsbA and MsbA reconstituted in 
proteoliposomes (Fig. S7). In contrast to detergent-
purified MsbA, DARPin_55 did not bind to the 
membrane-embedded transporter indicating that the 
binding epitope on MsbA cannot be accessed by 
DARPin_55 because it is (at least partially) masked 
by the lipid bilayer. 
 
Cysteine cross-linking of DARPin and MsbA 
mutants – In order to further specify the binding 
epitope of DARPin_55 on MsbA, single cysteines 
were introduced into MsbA and DARPin_55 and 
proximities between these cysteines were detected 
using the thiol-specific homobifunctional cross-
linkers M5M and M11M. A total of nine single 
cysteine mutants were made at different positions in 
the cytoplasmic part of the TMD of MsbA and in 
DARPin_55 (four in MsbA at positions 103, 191, 
206 and 246 and five in DARPin_55 at positions 12, 
16, 29, 151 and 160). Using ELISA, each mutated 
DARPin was confirmed to bind to every single 
cysteine MsbA mutant (data not shown). All 
possible combinations of MsbA and DARPin_55 
cysteines mutants were then cross-linked as 
described in the experimental procedures. The single 
cysteine mutants of MsbA alone did not form any 
cross-linked products in the presence of M11M and 
M5M (Fig. 3A) nor could any of the DARPin 
mutants be cross-linked to cys-less MsbA (Fig. S8). 
Cysteines introduced at the N-terminus of 
DARPin_55 (at positions 12, 16 and 29) were 
efficiently cross-linked to MsbA_191C and to a 
lesser extent to MsbA_206C and MsbA_246C with 
both cross-linkers (Fig. S8). MsbA_103C formed 
only faint cross-linking products with all DARPin 
mutants tested. Likewise, the cysteines at the C-
terminus of DARPin_55 (at positions 151 and 160) 
were only poorly cross-linked with the four MsbA 
single cysteine mutants with either cross-linker. 
These faint cross-linking products seemed 
promiscuous and were therefore considered as 
background. In summary, the N-terminus of 
DARPin_55 is in close proximity to the 
MsbA_191C position whereas the orientation of the 
C-terminal part of DARPin_55 could not be resolved 
by only this analysis. 
 
One molecule of DARPin_55 binds to the MsbA 
homodimer – The maximal degree of DARPin cross-
linking to MsbA never seemed to exceed 50 % of the 
MsbA chains (Fig. S8). To further investigate this 
phenomenon, cross-linking between 
DARPin_55_29C and MsbA_191C was carried out 
in the absence of nucleotides as well as in the 
presence of AMP-PNP or ATP-vanadate using 
increasing amounts of DARPin (Fig. 3). 
Interestingly, cross-linking was saturated at a 
stoichiometry of approximately one DARPin 
binding to homodimeric MsbA in its apo-state (Fig. 
3A). The exact stoichiometry was quantified by 
SYPRO Ruby staining to 0.73 ± 0.01 DARPins 
cross-linked to MsbA (Fig. 4A). The presence of 
AMP-PNP or ATP-vanadate appears to diminish the 
cross-linking reaction (Fig. 3B and C), which might 
be caused by a longer distance between the thiol-
groups in this state (see EPR data below) and/or a 
decreased binding affinity of the DARPin for the 
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nucleotide-bound state(s) of MsbA. Despite multiple 
attempts, we were not able to perform surface 
plasmon resonance (SPR) measurements which 
would have allowed for the determination of binding 
constants of DARPin_55 recognizing different 
conformational states of MsbA. The ATPase activity 
of the DARPin_55_29C/MsbA_191C complex is 
stimulated by a factor of two compared to 
MsbA_191C alone and remains unchanged upon 
cross-linking using M11M (Fig.3D). This indicates 
that the DARPin_55 remains bound to MsbA during 
its entire catalytic cycle.   Binding stoichiometries 
were further studied by gel filtration experiments. 
The MsbA/DARPin_55 complex was separated from 
excess DARPin_55 by size-exclusion 
chromatography (Fig. S4) followed by a quantitative 
analysis of DARPin_55 and MsbA using the protein 
chip technology (Agilent Technologies) (Fig. S9). In 
agreement with the cross-linking results, the ratio 
between DARPin_55 and MsbA dimer was 
quantified to 0.8. The binding stoichiometries in the 
gel filtration assay as well as in the cross-linking 
experiment were slightly less than one DARPin 
bound per MsbA dimer. For the gel filtration assay, 
this is likely due to partial dissociation of 
DARPin_55 from MsbA during the size-exclusion 
run whereas in the cross-linking experiment, some of 
the thiol-moieties of the cysteines might have 
undergone oxidation during the purification and as a 
consequence would not react with the 
methanethiosulfonate cross-linker. At this point, two 
scenarios can explain the binding stoichiometry of 
one DARPin bound per homodimeric MsbA: i) 
Binding of the first DARPin molecule to MsbA 
sterically prevents binding of the second or ii) the 
DARPin recognizes asymmetries in MsbA.  
 
EPR-distances between DARPin_55 and MsbA – 
In order to rule out possible steric clashes between 
the two DARPins in the complex, the binding 
epitope of DARPin_55 on MsbA was mapped by 
EPR. Various combinations of five spin-labeled 
single cysteine mutants spanning the MsbA structure 
(positions 25, 65, 103, 191, 482) and two spin-
labeled DARPin_55 (positions 29 or 160) were 
measured to extract interspin distances by DEER.  
Due to the 1:1 stoichiometric ratio between 
DARPin_55 and MsbA, binding of one spin-labeled 
DARPin to the homodimeric spin-labeled transporter 
gives rise to a three-spin complex. This was 
confirmed by measuring the spin concentration in 
the MsbA-DARPin complexes using continuous 
wave EPR (data not shown). To disentangle the 
intra-MsbA from the MsbA-DARPin distances, we 
measured the MsbA alone and in the presence of the 
DARPin. To reduce the known effects of three-spin 
artefacts in the distance distributions (44), the intra-
MsbA and the MsbA-DARPin distances should be 
as distinct as possible. 
Among all combinations tested, only two 
(MsbA_191R1-DARPin_55_29R1 and 
MsbA_65R1-DARPin_55_160R1, with R1 denoting 
the MTSSL spin-labeled side chain) resulted in 
extractable MsbA-DARPin distances (Fig. 5) (all 
DEER distances are presented in Fig. 6). The intra-
MsbA_191R1 distances in the apo- and AMP-PNP- 
states are shown in Fig. 5A. Addition of 
DARPin_55_29R1 resulted in the appearance of a 
short distance peak at 1.5-2 nm confirming the close 
proximity of the N-terminal region (N-cap) of the 
DARPin_55 to the position 191 in the TMDs already 
observed by cross-linking (Fig. S8). Interestingly, 
the distance between these two positions becomes 
slightly longer (~2 nm) in the presence of AMP-
PNP, whereas the intra-MsbA_191R1 distance 
remains unchanged as seen above with unlabeled 
DARPin_55 (Fig. 5A, lower panel and Fig. 2A). The 
longer distance observed between the two nitroxide 
labels in MsbA and DARPin_55 might explain the 
reduced degree of M11M mediated cross-linking 
observed upon addition of nucleotides (Fig. 3B and 
C).  
Whereas the position of the N-cap of DARPin_55 
with respect to the TMD could be readily mapped by 
cross-linking and EPR, the orientation of the 
DARPin’s C-cap was challenging to find, also 
because no cross-link could be established between 
the 151 and 160 positions of DARPin_55 and any of 
the MsbA mutants used (Fig. S8). After screening by 
DEER a number of complexes with DARPin_55 
labeled at the C-cap (position 160), we found a clear 
distance constraint between the C-cap and the 
extracellular region of the transporter (position 65). 
According to the structural changes expected from 
the X-ray data, addition of AMP-PNP to isolated 
MsbA resulted in an increase of the 65-65 distance 
from 4 to 6 nm (Fig. 4B). When DARPin_55_160R1 
was analyzed in complex with MsbA_65R1, we 
found a distinct MsbA-DARPin_55 distance 
centered at 3.9 nm in the AMP-PNP state, whilst the 
overlap with the intra-MsbA distance prevented a 
clear MsbA-DARPin_55 distance assignment in the 
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apo state. In contrast, we could exclude distances < 5 
nm between the C-cap of DARPin_55 and the other 
positions in the NBDs (position 482) and in the 
cytoplasmic-facing region of the TMDs (positions 
25, 103, 191) (Fig. 6). Based on these observations 
we could rule out that the C-cap is oriented towards 
the NBDs, thus the transmembrane domain of MsbA 
seems to be covered at least partially by the 
DARPin_55. Importantly, the DARPin binding 
epitope was found to be far away from the 2-fold 
symmetry axis of MsbA, thus ruling out the 
possibility of steric clashes between two DARPins 
as the cause for the stoichiometric ratio observed.  
 
 
The ATPase sites of asymmetrically stabilized 
MsbA display different nucleotide binding properties 
– Cross-linking DARPin_55_29C to asymmetric 
MsbA_191C provides the unprecedented advantage 
that the conformationally unequal chains of 
homodimeric MsbA can be separated by SDS-
PAGE, thus questions as whether the two ATPase 
sites of asymmetric MsbA display differences with 
respect to nucleotide binding can be for the first time 
addressed. The cross-linked DARPin-MsbA 
complex was incubated with 8-N3-[α-
32
P]ATP 
followed by UV cross-linking of the nucleotide to 
the two chains of MsbA. Subsequently, the proteins 
were separated by SDS-PAGE and the amount of 
cross-linking was determined by autoradiography 
(Fig. 4). The ratio between the bands of DARPin_55 
cross-linked to MsbA and MsbA alone was 
quantified to be 0.73 ± 0.01 by SYPRO Ruby 
staining. Interestingly, the MsbA chain cross-linked 
to DARPin_55 showed a stronger photolabeling 
with 8-N3-[α-
32
P]ATP than the MsbA chain alone 
(ratio between MsbA-DARPin55 to MsbA of 1.39 ± 
0.07). This indicates that the MsbA monomer to 
which the DARPin was cross-linked to was 
photolabeled 1.9 times stronger than the free MsbA 
chain. 
 
DISCUSSION 
Asymmetries in the NBDs of ABC exporters 
arising from trapping of nucleotides by vanadate 
have been discussed since the mid-nineties when 
Urbatsch and Senior first described the catalytic 
cycle of P-glycoprotein and later were also found in 
the homodimeric transporter BmrA (16,17). Using 
an in vitro selected DARPin binder, we provide here 
novel evidence supporting considerable asymmetries 
to be found in a well-studied ABC exporter.  
Our biochemical analysis shows that DARPin_55 
binds to the TMDs of MsbA in a stoichiometry of 
one DARPin per homodimeric transporter. The 
binding epitope was mapped to the TMDs of MsbA 
and therefore, the possibility that binding of the first 
DARPin sterically hinders binding of a second 
DARPin to the symmetry-related epitope on MsbA 
could be excluded. In further support of this notion, 
DARPin binding does not affect the closure of the 
NBDs and the transition to the outward-facing state 
of MsbA upon addition of AMP-PNP. The DARPin 
therefore recognizes asymmetries in MsbA. 
Asymmetric homodimers are not unusual. The 
epidermal growth factor receptor from Drosophila 
has been recently crystallized in an asymmetric state 
in complex with two growth factor ligands binding 
in a low- and a high-affinity mode (45). Caspase-9 is 
activated by dimerization and was crystallized as 
asymmetric homodimer exhibiting one active and 
one inactive catalytic site (46). However, despite 
serious efforts we did not succeed to solve the co-
crystal structure of the MsbA-DARPin_55 complex 
and therefore the molecular details of the 
asymmetries in MsbA remain elusive.  
Epitope mapping revealed that the DARPin 
binding site includes membrane-spanning portions 
of the TMD (Fig. 6). There are two observations 
which further support this unexpected finding. First, 
DARPin_55 only binds to MsbA in its detergent-
purified but not in its membrane-bound form (Fig. 
S7). In a detergent-purified MsbA sample, free 
detergent monomers, protein-free detergent micelles 
and detergent bound to the membrane protein are in 
equilibrium (47). There is constant rapid exchange 
of detergents molecules between these pools. Lipid 
bilayers in contrast are more rigid (48). It is 
therefore likely that DARPin_55 partly displaces the 
detergent micelle, but not the relatively stiffer lipid 
membrane to bind to its epitope. Second, in 
agreement with the positioning of DARPin_55 with 
respect to the membrane boundary, the randomized 
positions in the β-turns of the second and the third 
DARPin repeat exclusively harbor hydrophobic 
amino acids (Fig. S10). These residues could 
mediate hydrophobic contacts with the 
transmembrane helices of MsbA, whereas in the first 
repeat, there are two glutamates which could interact 
with the cytoplasmic portion of the TMD. 
Importantly, DARPin_55 only recognizes MsbA, but 
 at H
auptbibliothek U
niversitaet Zuerich Irchel. Bereich Forschung on M
arch 10, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
  Asymmetry in MsbA recognized by a DARPin 
 
 9 
not its homologue LmrCD or the multidrug 
transporter AcrB. Therefore, unspecific hydrophobic 
interactions of DARPin_55 with membrane proteins 
in general can be excluded. Interestingly, the 
presence of DARPin_55 increased the ATPase 
activity of the β-UDM-solubilized transporter by 
influencing the Vmax term, independent of the 
substrate-induced stimulations. This finding is 
reminiscent of a recent biochemical characterization 
of the P-glycoprotein-specific antibody MRC16 the 
addition of which was found to increase the ATPase 
activity of the transporter in the absence as well as in 
the presence of the substrate nicardipine (49). 
It has often been argued that in vitro selected 
binding proteins may distort the target protein 
thereby trapping it in an unnatural and non-
physiological state. However, numerous examples of 
crystal structures solved alone and in complex with a 
binding partner in very similar conformations speak 
against this argument (as reviewed in (24,50,51)). 
One prominent example reminiscent to the study 
presented here is the homotrimeric multidrug 
transporter AcrB, that has been crystallized alone 
and in complex with DARPins in an asymmetric 
conformation in which each conformer represents a 
consecutive step of the transport cycle (25,27,28). 
Only two DARPins were found to bind to the trimer, 
and at the third expected DARPin binding site, a 
steric clash between a conformationally altered 
subdomain of AcrB with the back side of the 
DARPin prevented binding (25,26). The DARPins 
did not induce the asymmetric state, but rather 
recognized the intrinsic asymmetry of the targeted 
protein. It is therefore plausible that the asymmetric 
conformational states of MsbA to which 
DARPin_55 binds to belong to the intrinsic 
ensemble of possible conformations of the 
transporter.  
DEER and cross-linking experiments show that 
DARPin_55 binds to homodimeric MsbA in the apo-
state as well as in the presence of AMP-PNP and 
ATP-vanadate and therefore the recognized 
asymmetries in MsbA do not appear to be state-
specific. In support of this notion, cross-linked 
MsbA-DARPin complexes retain their increased 
ATPase activity suggesting that the DARPin 
remains bound during the entire catalytic cycle. 
Importantly, DARPin binding does not trap MsbA in 
an asymmetric state, which would lead to an 
inhibition of the ATPase activity, but rather enables 
the transporter to inter-convert between 
conformations necessary for function at a higher 
rate. Our findings stand in partial contrast to a recent 
study on P-glycoprotein antibodies MRK16 and 
UIC2, which were shown to bind to the transporter 
in the apo-state as well as in the presence of AMP-
PNP (pre-hydrolytic state), but not if the transporter 
is trapped with ADP-vanadate (post-hydrolytic state) 
(49). In addition to earlier studies dealing with the 
asymmetric nature of the catalytic cycle at the NBDs 
(16,17), our results indicate that distinct 
asymmetries also inhere to the TMDs of MsbA 
where the DARPin_55 epitope is located. Lipid A, 
the natural substrate of MsbA, is rather big 
(molecular weight of around 1.8 kDa) and 
asymmetric. Therefore, it is plausible to assume that 
only one molecule of lipid A can be accommodated 
by the substrate binding cavity of MsbA which 
might require asymmetries in the TMDs. We found 
that the ATPase activity of detergent-purified MsbA 
was stimulated by lipid A and daunomycin. Our 
observations with lipid A agree with a previous 
study (41), although the stimulation observed by us 
is not as pronounced as reported, whereas in the 
same study stimulation of the ATPase by 
daunomycin was not apparent. These differences 
might arise from the different detergents used for 
purification of MsbA (β-UDM in our case and β-DM 
in the mentioned study (41)). Interestingly, the 
stimulation of MsbA’s ATPase activity by lipid A or 
daunomycin and DARPin_55 are additive (Fig. 1D 
and E). DARPin binding therefore does not seem to 
interfere with substrate interactions at the binding 
cavity. 8-N3-[α-
32
P]ATP was shown to preferentially 
photolabel one of the chains of asymmetric 
homodimeric MsbA, hence supporting the notion 
that the asymmetries recognized by the DARPin at 
the TMDs are conformationally linked to the 
nucleotide binding sites at the NBDs and vice versa. 
Since photocross-linking using 8-N3-[α-
32
P]ATP is a 
non-equilibrium binding method, further 
biochemical analyses are difficult. Nevertheless, in 
symmetric MsbA both nucleotide binding sites are 
identical and expected to be labeled by equal 
amounts of 8-N3-[α-
32
P]ATP. This is not the case 
and therefore, the two nucleotide binding sites are 
different from each other. As previously proposed 
based on biochemical experiments and molecular 
dynamics simulations, the asymmetric switching at 
the NBDs might be a prerequisite for ATP 
hydrolysis (16,17,19,21). Our data suggest that 
DARPin binding to MsbA populates asymmetric 
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states of the transporter from an ensemble of 
structurally similar conformations which exhibits 
increased basal ATPase activities and is fully 
compatible with its function to bind lipid A and 
drugs.  
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FIGURE LEGENDS 
 
Figure 1. Characterization of DARPin_55: Specificity, epitope mapping and modulation of ATPase activity 
of MsbA. A ELISA to determine binding specificity of DARPin_55. DARPin_55 specifically binds to its target 
protein bMsbAAviC but not to the control proteins bLmrCDAviC and bAcrBAviC. DARPin_110819 specifically 
recognizing bAcrBAviC was used as a control. B ELISA assay to delineate DARPin_55 binding to subdomains of 
MsbA. DARPin_55 binds to the transmembrane domain (bTMDAviC) but not to the nucleotide binding domain 
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(bNBDAviC) of MsbA. bAcrBAviC is used as a negative control. C Modulation of basal ATPase activity of 
detergent-solubilized MsbA in complex with DARPin_55. DARPin_55 was added to MsbA (200 nM) in a two-
fold serial dilution series ranging from 50 nM to 1.6 µM leading to a stimulation of the ATPase activity of MsbA 
by up to 2.1-fold. Addition of the unselected DARPin E3_5 (1 µM) to MsbA does not increase its ATPase 
activity. DARPin_55 (1 µM) alone does not hydrolyze ATP. D The ATPase activity of MsbA was determined in 
the presence of DARPin_55 (1 µM) or E3_5 (1 µM) as well as in absence of DARPins at varying ATP 
concentrations. Addition of DARPin_55 results in a higher maximal rate of ATP hydrolysis (Vmax), while the 
apparent affinity for ATP (Km) is not affected. E and F The stimulations of the ATPase activity of MsbA by 
substrates and DARPin_55 are additive. Lipid A was added to detergent-purified MsbA at concentrations of 0, 
0.05, 0.1 and 0.2 mg/ml E,  daunomycin was added at concentrations of 0, 50, 100 and 200 µM F and ATPase 
was measured in the absence and presence of DARPin_55 (1 µM). Error bars represent standard deviations. 
 
Figure 2. Intra-MsbA distance measurements by DEER reveal no major conformational changes of the 
transporter upon binding of wild-type DARPin. A Left, normalized DEER form factors F(t) and fits obtained 
with DeerAnalysis2010 on detergent-purified MsbA_191R1 alone and in complex with wild-type DARPin_55. 
Traces were detected in the apo-state and in the AMP-PNP-state (5 mM AMP-PNP and 5 mM MgCl2) in the 
absence and in the presence of DARPin_55, as indicated. Right, distance distributions obtained with Tikhonov 
regularization parameters 100 or 1000. The intra-MsbA distances simulated based on the AMP-PNP X-ray 
structure (PDB 3B60) are superimposed (red dotted). B DEER analysis on MsbA_539R1 alone and in complex 
with DARPin_55 analogous to A.  
 
Figure 3. Methanethiosulfonate-mediated cross-linking of one DARPin to homodimeric MsbA. A to C 
MsbA_191C (1 µM) was incubated with increasing amounts of DARPin_55_29C (from 500 nM to 16 µM) in the 
absence of nucleotides A, in the presence of MgCl2 (3.5 mM) and AMP-PNP (3 mM) B, or ATP-vanadate (2.5 
mM, each) C. The protein complexes were cross-linked using the homobifunctional M11M cross-linker (2 mM) 
for 15 minutes at 4°C and separated by non-reducing SDS-PAGE. D ATPase activities of cross-linked 
MsbA191C-DARPin_55_29C complexes are equal to those of non-treated MsbA-DARPin complexes and are 
consistently increased by a factor of two compared to MsbA alone.  
 
Figure 4. Preferential nucleotide binding to one chain of asymmetrically stabilized MsbA as determined by 
8-N3-[α-
32
P]ATP photolabeling A and B DARPin_55_29C was cross-linked to MsbA_191C using M11M, 
followed by addition of 8-N3-[α-
32
P]ATP (1 µM) and UV-cross-linking (performed as quadruplicates). The 
samples were separated by non-reducing SDS-PAGE and analyzed by SYPRO Ruby staining A and 
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autoradiography B. C The band intensities corresponding to cross-linked DARPin-MsbA complex and free MsbA 
monomer obtained in A and B were quantified.  
 
 
Figure 5. Determination of the binding epitope of DARPin_55 by DEER. A Left, normalized DEER form 
factors F(t) and fits obtained with DeerAnalysis2010 on detergent-purified MsbA_191R1 alone and in complex 
with DARPin_55 spin labeled at position 29 (N-cap). Traces were detected in the apo-state and in the AMP-PNP-
state (5 mM AMP-PNP and 5 mM MgCl2) in the absence and in the presence of DARPin_55_29R, as indicated. 
Right, distance distributions obtained with Tikhonov regularization parameters 100 or 1000. Assigned MsbA-
DARPin distances are marked in the distance distribution. B DEER analysis on MsbA_65R1 alone and in 
complex with DARPin_55 spin labeled at position 160 (C-cap) analogous to A. The vicinity of the intra-MsbA 
and DARPin-MsbA distances in the apo-state prevented a clear assignment of the DEER constraint. 
 
Figure 6. The MsbA-DARPin complex based on cross-linking and DEER data. A Overview of the cross-
linking data (Fig. S8) using the X-ray structure of MsbA (PDB 3B60) and a homology model of DARPin_55 as 
templates. The black straight lines indicate thiol-pairs showing strong cross-links, the black dotted lines denote 
pairs showing weak cross-links. B Overview of interspin distances between MsbA and DARPin_55. The possible 
spin label rotamers attached at selected positions in MsbA were simulated using the Matlab program package 
MMM and are indicated as green clouds. The black straight lines highlight the pairs for which DEER constraints 
were obtained. All DEER data including the restraints are presented in the table.  
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